Characteristics of circulating CD31(+) cells from patients with coronary artery disease

Moo Hyun Kim1, Longzhe Guo, Han-Soo Kim

  • 1Department of Cardiology, College of Medicine, Dong-A University, Busan, Korea; Regional Clinical Trial Center, Dong-A University Hospital, Busan, Korea.

Insights

Circulating CD31(+) cells in coronary artery disease (CAD) patients show impaired angiogenic potential and are linked to cardiovascular disease activity. The number of these cells may serve as a biomarker for CAD severity.

Area of Science:

  • Immunology
  • Cardiovascular Biology

Background:

  • CD31-expressing cells' role in healthy individuals is known.
  • Characteristics of CD31-expressing cells in coronary artery disease (CAD) patients are unexplored.

Purpose of the Study:

  • Investigate the relationship between circulating CD31(+) cells and CAD.
  • Determine the biological characteristics of these cells in CAD patients.

Main Methods:

  • Flow cytometry analysis of peripheral blood CD31(+) cells.
  • Gene expression analysis for angiogenic, chemokine, and inflammatory markers.
  • Correlation analysis with cardiovascular disease activity and coronary artery disease severity.

Main Results:

  • CAD patient CD31(+) cells (C-CD31) display reduced T-cell and increased macrophage markers compared to healthy controls (H-CD31).
  • Pro-angiogenic and chemokine gene expression is down-regulated in C-CD31, while IL-1α is up-regulated.
  • Increased CD31(+) cells in peripheral blood of unstable angina patients; significant correlations found with disease activity and number of diseased coronaries.

Conclusions:

  • CD31(+) cells in CAD patients exhibit diminished angiogenic capacity.
  • Circulating CD31(+) cell counts correlate with cardiovascular risk and disease severity.
  • These findings offer insights into CAD pathogenesis and potential diagnostic markers.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
811